Related Experiment Video

Updated: Aug 2, 2026

Chromatin Immunoprecipitation (ChIP) to Assay Dynamic Histone Modification in Activated Gene Expression in Human Cells
13:20

Chromatin Immunoprecipitation (ChIP) to Assay Dynamic Histone Modification in Activated Gene Expression in Human Cells

Published on: July 29, 2010

[The role of SRC kinase in activation of transcription factor STAT1]

K P Vasilenko1, P A Butylin, A M Arnautov

  • 1Institute of Cytology RAS, St. Petersburg. shambala@mail.cytspb.rssi.ru

Tsitologiia
|February 14, 2002
PubMed

Insights

The study reveals that Src kinase, not JAK2, activates Signal Transducers and Activators of Transcription 1 (STAT1) signaling in response to epidermal growth factor (EGF) and hyperosmotic shock.

Area of Science:

  • Molecular Biology
  • Cell Signaling
  • Signal Transduction Pathways

Background:

  • Signal Transducers and Activators of Transcription 1 (STAT1) is a crucial transcription factor involved in cellular responses to growth factors and cytokines like interferons.
  • Tyrosine kinases play significant roles in mediating signal transduction pathways initiated by cell surface receptors.
  • Epidermal growth factor (EGF) and hyperosmotic shock are known cellular stressors that trigger distinct signaling cascades.

Purpose of the Study:

  • To investigate the specific roles of tyrosine kinases Src and JAK2 in the activation of STAT1.
  • To determine whether Src and JAK2 mediate STAT1 activation induced by epidermal growth factor (EGF) and hyperosmotic shock.

Main Methods:

  • Utilized a pharmacological inhibitor (CGP77675) specific for Src kinases.
  • Employed cells genetically modified to lack the c-src gene (knockout cells).
  • Assessed STAT1 activation following stimulation with EGF and hyperosmotic shock in the presence and absence of Src inhibition or knockout.

Main Results:

  • Src kinase activity was found to be essential for STAT1 activation in response to both EGF stimulation and hyperosmotic shock.
  • Inhibition or absence of Src kinase function abrogated STAT1 activation under these conditions.
  • JAK2 kinase activity did not demonstrate any significant influence on STAT1 activation by EGF or hyperosmotic shock.

Conclusions:

  • Src kinase is a key mediator of STAT1 activation triggered by EGF and hyperosmotic shock.
  • JAK2 is not involved in the STAT1 activation pathways stimulated by EGF or hyperosmotic shock.
  • These findings elucidate the specific upstream regulators of STAT1 in response to distinct cellular stimuli.

More Related Videos

Merging Absolute and Relative Quantitative PCR Data to Quantify STAT3 Splice Variant Transcripts11:19

Merging Absolute and Relative Quantitative PCR Data to Quantify STAT3 Splice Variant Transcripts

Published on: October 9, 2016

Analysis of the c-KIT Ligand Promoter Using Chromatin Immunoprecipitation09:40

Analysis of the c-KIT Ligand Promoter Using Chromatin Immunoprecipitation

Published on: June 27, 2017

Related Concept Videos

RNA Polymerase II Accessory Proteins02:36

RNA Polymerase II Accessory Proteins

Proteins that regulate transcription can do so either via direct contact with RNA Polymerase or through indirect interactions facilitated by adaptors, mediators, histone-modifying proteins, and nucleosome remodelers. Direct interactions to activate transcription is seen in bacteria as well as in some eukaryotic genes. In these cases, upstream activation sequences are adjacent to the promoters, and the activator proteins interact directly with the transcriptional machinery. For example, in...
Eukaryotic Transcription Activators02:42

Eukaryotic Transcription Activators

Transcription activators are proteins that promote the transcription of genes from DNA to RNA. In most cases, these proteins contain two separate domains ‒ a domain that binds to DNA and a domain for activating transcription; however, in some cases, a single domain is responsible for both binding and activation of transcription, as seen in the glucocorticoid receptor and MyoD.
The binding domains are capable of recognizing and interacting with regulatory sequences on the DNA. These domains are...
Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze the...
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...